Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 8:01 PM
Ignite Modification Date: 2025-12-24 @ 8:01 PM
NCT ID: NCT04633304
Eligibility Criteria: Inclusion Criteria: 1. Male or Female Age of at least 18 years 2. CKD 3 through 5 as measured by GFR 45 and under by MDRD equation on two separate occasions at least 3 months apart. 3. Provide written informed consent using a form that is approved by the Institutional Review Board (IRB) prior to collection of study data or performance of study procedures. 4. Currently not on hemodialysis. 5. Life expectancy of at least one year 6. Meets Anatomical Criteria for EndoAVF creation via pre-procedure Duplex or Venography Vascular anatomy suitable for creation of the AV fistula 7. Willing to comply with the specified follow-up evaluations Exclusion Criteria: 1. Anatomical exclusion criteria met 2. Thought to need dialysis within 30 days. 3. The subject is in a hypercoagulable state. 4. The subject has known bleeding diathesis. 5. The subject has insufficient cardiac output to support a native fistula in the opinion of the investigator. 6. Known history of active intravenous drug abuse. 7. The subject has a known allergy or hypersensitivity to contrast media which cannot be adequately pre-medicated. 8. The subject has known adverse effects to sedation and/or anesthesia which cannot be adequately pre-medicated. 9. Evidence of active infection on the day of the index procedure (temperature of ≥ 38.0° Celsius and/ or WBC of ≥ 12,000 cells/ μL, if collected).
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT04633304
Study Brief:
Protocol Section: NCT04633304